IOM: FDA Should Abandon 510(k) But Agency, Industry Disagree

The FDA should abandon its 510(k) device clearance process and develop a new regulatory framework for low- and moderate-risk medical devices, a report by the Institute of Medicine (IOM) suggests.
Devices & Diagnostics Letter